Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 25, 820-826, July 1, 1965]
© 1965 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elwood, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elwood, J. C.

Glycolysis and Respiration

I. A Cell-free Sarcoma 37 Ascites Tumor Preparation1

J. C. Elwood

( Biochemistry Department, Upstate Medical College, State University of New York, Syracuse, New York)

A cell-free system of Sarcoma 37 ascites cells which respired and glycolyzed readily has been studied. The addition of DPN2 to the system was required for maximal respiration. The fortified preparation compared favorably in magnitude of oxygen consumption and glucose utilization with the intact Sarcoma 37 cells. Citrate, glucose, glucose-1-P, glucose-6-P, fructose, and 2-deoxyglucose all stimulated respiration in the homogenate system beyond endogenous respiration. Acetate, pyruvate, and 2-deoxyglucose-6-P did not stimulate respiration.

Changes in the concentration of Pi in a glycylglycine-buffered medium affected glycolysis and respiration in intact cells and in the cell-free system. Respiration was decreased in whole cells at Pi concentrations greater than 100 µmoles per flask. The cell-free preparation showed diminished respiration at concentrations below 10 µmoles of Pi per vessel and above 50 µmoles per vessel. Optimal lactate production was obtained with 1 µmole of Pi per vessel in intact cells and in the cell-free system. Lactic acid production was decreased in a Pi-free medium in whole cells and in the broken cell system. Lactic acid production was also decreased in both systems at Pi levels above 100 µmoles per flask. The disappearance of glucose was directly related to the lactic acid produced; i.e., the more glucose used, the more lactate produced. Glucose oxidation was influenced by Pi concentration. Glucose-1-14C oxidation was decreased at high Pi concentration in the intact cells and in the homogenate; oxidation was maximal at concentrations greater than 100 µmoles per vessel. There was decreased oxidation of glucose-6-14C in both systems at high Pi concentration, i.e., greater than 50 µmoles per flask.

Oxygen consumption was unaffected by the addition of ATP, ADP, or AMP to a glycolyzing preparation of broken cells. However, ATP, ADP, and AMP did affect glycolysis in this system. Glucose disappeared faster and lactate was formed more rapidly in the presence of the adenine nucleotides. The intact cells and homogenate systems were shown to oxidize glucose by non-Embden-Meyerhof pathways. Respiration due to glucose utilization was shown to increase from more than 20% in the 1st hr of incubation to more than 70% during the 3rd hr in both systems. The addition of TPN to the cell-free preparation did not influence respiration but had an effect on glycolysis during the 30- to 60-min incubation period. The oxidation of glucose-1-14C to 14CO2 was greatly enhanced in the presence of TPN, indicating that the level of TPN was limiting for glucose oxidation in the unfortified system.

1 This investigation was supported in part by USPHS grant CA-06194, from the National Cancer Institute.

2 The following abbreviations are used: DPN and DPNH, diphosphopyridine nucleotide and its reduced form; glucose-1-P, glucose-1-phosphate; Pi, orthophosphate; ATP, adenosine triphosphate; ADP, adenosine diphosphate; AMP, adenosine monophosphate; TPN, triphosphopyridine nucleotide; P-enolpyruvate, phosphorylenolpyruvate.

Received 12/14/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1965 by the American Association for Cancer Research.